MapLight Therapeutics MPLT Growth Metrics (2024-2026)

NASDAQ MPLT
$8.24 +0.24 (+3.00%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

MapLight Therapeutics Quarterly Growth Metrics

Periods 4 quarters
Latest Jun 2026

MapLight Therapeutics growth metrics data for the quarter ended Jun 2026. These growth metrics cover 4 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Dec2024 Sep2025 Dec2025 Jun2026
Growth Ratios
Assets Growth (1y) 250.22%
Assets (QoQ) 86.42%
Capital Expenditures Growth (1y)Capex Growth (1y) 254.72%
Capital Expenditures (QoQ)Capex (QoQ) 1,112.90%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 22.16%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -27.15%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y) -848.76%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ) -78.89%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -117.93%
Cash from Operations (QoQ)Cash from Ops. (QoQ) -47.30%
EBIT Growth (1y) -50.75%-266.06%-107.25%
EBIT (QoQ) -9.01%-2.72%-164.71%
EBT Growth (1y) -51.16%-269.81%-104.17%
EBT (QoQ) -10.42%0.09%-170.15%
EPS (Basic) Growth (1y) -48.26%68.22%96.61%
EPS (Basic) (QoQ) -14.98%4.93%75.36%
EPS (Diluted) Growth (1y) -48.26%68.22%96.61%
EPS (Diluted) (QoQ) -14.98%4.93%75.36%
Free Cash Flow Growth (1y)FCF Growth (1y) -118.60%
Free Cash Flow (QoQ)FCF (QoQ) -48.34%
Net Cash Flow Growth (1y)NCF Growth (1y) -259.63%
Net Cash Flow (QoQ)NCF (QoQ) -156.77%
Net Income Growth (1y) -54.70%-274.71%-101.68%
Net Income (QoQ) -11.64%1.43%-170.41%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -54.70%-274.71%-101.68%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -11.64%1.43%-170.41%
Operating Income Growth (1y)Op. Inc Growth (1y) -50.75%-266.06%-107.25%
Operating Income (QoQ)Op. Inc (QoQ) -9.01%-2.72%-164.71%
Profit After Tax Growth (1y)PAT Growth (1y) -51.16%-269.81%-104.17%
Profit After Tax (QoQ)PAT (QoQ) -10.42%0.09%-170.15%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) -9.28%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) 27.47%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) -64.69%16,498.60%5,728.38%
Share-based Compensation (QoQ)Stock Comp. (QoQ) -39.55%-15.54%28,316.80%

MapLight Therapeutics Growth Metrics API

Pull MapLight Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MPLT&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY